Prevalence estimates of chronic kidney disease in Canada: Results of a nationally representative survey

CMAJ. Canadian Medical Association Journal

Volumn 185, Issue 9, 2013, Pages

  Arora, Paul ^a,b   Vasa, Priya ^c   Brenner, Darren ^b   Iglar, Karl ^c   McFarlane, Phil ^d   Morrison, Howard ^a   Badawi, Alaa ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; ARTICLE; CANADA; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; EARLY INTERVENTION; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY DYSFUNCTION; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; SECONDARY PREVENTION;

EID: 84878836172     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.120833     Document Type: Article

References (28)

1. Levin A, Hemmelgarn B, Culleton B, et al. Guidelines for the management of chronic kidney disease. CMAJ 2008;179:1154-62.
2. Stigant C, Stevens L, Levin A. Nephrology: 4. Strategies for the care of adults with chronic kidney disease. CMAJ 2003;168:1553-60. (Pubitemid 36741195)
3. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47. (Pubitemid 350074801)
4. Levey AS, Coresh J. Chronic kidney disease. Lancet 2012;379:165-80.
5. Genest J, McPherson R, Frohlich J, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 2009;25:567-79.
6. Chalmers L, Kaskel FJ, Bamgbola O. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Adv Chronic Kidney Dis 2006;13:352-64. (Pubitemid 44512239)
7. Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004;291:844-50. (Pubitemid 38543772)
8. Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010;303:423-9.
9. Foster MC, Hwang SJ, Larson MG, et al. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med 2007;167:1386-92. (Pubitemid 47052437)
10. Astor BC, Matsushita K, Gansevoort RT, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011;79:1331-40.
11. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011;80:17-28.
12. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32(Suppl 1):S1-201.
13. Campbell NR, Khan NA, Hill MD, et al. 2009 Canadian Hypertension Education Program recommendations: the scientific summary - an annual update. Can J Cardiol 2009;25:271-7.
14. Manns B, Hemmelgarn B, Tonelli M, et al. Population based screening for chronic kidney disease: cost effectiveness study. BMJ 2010;341:c5869.
15. Giroux S. Canadian Health Measures Survey: sampling strategy overview. Health Rep 2007;18(Suppl):31-6.
16. Tremblay M, Wolfson M, Gorber SC. Canadian Health Measures Survey: rationale, background and overview. Health Rep 2007;18(Suppl):7-20.
17. Colapinto CK, O'Connor DL, Tremblay MS. Folate status of the population in the Canadian Health Measures Survey. CMAJ 2011;183:E100-06.
18. Bryan S, St-Denis M, Wojtas D. Canadian Health Measures Survey: clinic operations and logistics. Health Rep 2007;18(Suppl):53-70.
19. Canadian Health Measures Survey: data user guide (cycle 1). Ottawa (ON): Statistics Canada; 2012. Available: www.statcan.gc.ca /imdb-bmdi/document/5071- D2-T1-V1-eng.htm (accessed 2012 Mar. 15).
20. Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012;307:1941-51.
21. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
22. National Kidney Disease Education Program. Estimating GFR. Bethesda (MD): The Program; 2012. Available: www.nkdep.nih.gov/lab-evaluation/gfr/estimating. shtml (accessed 2012 Mar. 15).
23. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(Suppl 1):S1-266.
24. Goldenberg RM, Cheng AYY, Punthakee Z, et al. Position statement: use of glycated hemoglobin (A1C) in the diagnosis of type 2 diabetes mellitus in adults. Can J Diabetes 2011;35:247-49.
25. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008;8:117.
26. Garg AX, Kiberd BA, Clark WF, et al. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int 2002;61:2165-75. (Pubitemid 34539334)
27. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008;371:2173-82. (Pubitemid 351890412)
28. Riediger ND, Clara I. Prevalence of metabolic syndrome in the Canadian adult population. CMAJ 2011;183:E1127-34.